Insider Transactions Reported by 19 Insiders of CinCor Pharma, Inc.

Location
Waltham, MA

There are no Buy or Sell transactions made by insiders since 02 Feb 2025

CinCor Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ATLANTIC GENPAR (BERMUDA) L.P. GENERAL 10%+ Owner $244,920,113 11 Aug 2022
L.P. GENERAL ATLANTIC 10%+ Owner $244,920,113 11 Aug 2022
Sofinnova Venture Partners X, L.P. 10%+ Owner $174,626,034 11 Aug 2022
Sofinnova Partners SAS 10%+ Owner $121,353,146 15 Aug 2022
CinRx Pharma, LLC 10%+ Owner $104,365,461 11 Jan 2022
Mary Theresa Coelho EVP CFO & Chief BD Officer $2,875 11 Jan 2022
Atlantic (CIN) L.P. General 10%+ Owner 06 Jan 2022
Mason Freeman Chief Medical Officer 26 Jan 2023
Catherine Pearce Chief Operating Officer 24 Feb 2023
Maina Bhaman Director 06 Jan 2022
Marc de Garidel Chief Executive Officer, Director 24 Feb 2023
David D. Allison Director 24 Feb 2023
JAMES HEALY Director, 10%+ Owner 28 Nov 2022
Jason Pitts Director 06 Jan 2022
JOHN F. THERO Director 24 Feb 2023
June Lee Director 24 Feb 2023
Michael W. Kalb EVP & Chief Financial Officer 24 Feb 2023
Troy A. Ignelzi Director 24 Feb 2023
5AM Partners VI, LLC 10%+ Owner 24 Feb 2023

Recent Insider Transactions by Companies or Individuals for CinCor Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.